Peru Lauds Sinopharm's COVID-19 Vaccine
Peru Lauds Sinopharm's COVID-19 Vaccine
BEIJING--August 30, 2021--Researched by Industrial Info Resources (Sugar Land, Texas)--According to Peru's Ministry of Health, China's Sinopharm vaccine has reduced Peru's COVID-19 mortality rate by 98% among those who received two doses. Only 5.2% of those vaccinated were later infected, and at least 9% were able to produce neutralizing antibodies.
Subscribe Now!(All Fields Required)
Related Articles
Articles related to this company
- Pharma Company Zoetis Signs PPA with Scout Clean Energy to Support Growing ...
- Suffolk Construction Has Hand in $1.9 Billion Worth of Projects
- U.S. Home to Billions' Worth of 2Q ESG Project Kickoffs
- Japan Hosts $832 Million in CDMO/CMO-Related Pharma Projects
- Turner Construction Involved in More than $24 Billion Worth of U.S. Project...